AKT1 and neoplasm: Inhibition of the cell cycle, induction of apoptosis, activation of the immune system, and interference with key signaling pathways such as EGFR, Nrf2/p62, and miR-7-5p/Akt/Wnt-β-catenin were some of the proposed underlying anti-tumor mechanisms mediated by PA-MSHA.